Extra Cellular Matrix (ECM)

Human Extra Cellular Matrix (hECM) derived from Umbilical Cord

Patent Filed Umbilical Cord Sourced Sustainable Biomaterial

Human Extra Cellular Matrix (hECM) is a natural, bioactive material derived from decellularized human umbilical cords. Retaining key structural proteins, collagen, and growth factors, it is available as powders, hydrogels, bioinks, and sheets to support cell adhesion, proliferation, and tissue repair.

Description

Available Sizes

Powdered hECM 300-350 PKR / mg
Hydrogel formats Custom Formulation

Advanced ECM Applications

Wound & Skin Care

Promotes rapid healing in severe burn wounds, diabetic foot ulcers, and chronic sores.

Orthopedic Scaffolds

Infused into bone fillers to enhance cellular seeding and bone/cartilage regrowth.

Injectable Hydrogels

Minimally invasive therapy for deep tissue voids and joint cartilage repair.

3D Bioprinting

Essential bioink component for printing functional organs and vascular channels.

Cancer Models

Mimics the native tumor microenvironment for laboratory cancer drug testing.

Bioactive Coatings

Enhances bone and tissue bonding on metallic implants and fixations.

Technology Status & Commercialization

Patent Status: National patent filed on decellularization procedure. ECM is a sustainable biopolymer, so DRAP approval is not required. Scale-up funding is required.

Business Potential

Import Substitution

Cuts high cost of importing research-grade and clinical-grade human ECM.

Clinically Superior

Offers superior tissue integration compared to animal-derived or synthetic polymers.

Start-up Expansion

Scalable platform technology forming the basis of a future high-growth IRCBM startup.

Rich in Native Growth Factors Minimal Immunogenicity Sustainable Cord Sourcing

Principal Investigator

Dr. Hafiza Fakhera Ikram

Associate Professor
Member of Soft Tissue Research Group

IRCBM - CUI Lahore Campus

fakhera.ikram@cuilahore.edu.pk

Research Group

Products and Commercial Technologies